Ignite Creation Date:
2024-10-26 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06505967
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-11
Brief Title:
Effectiveness of Qualia NAD Supplementation on Intracellular NAD Levels
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Effectiveness of Qualia NAD Supplementation on Intracellular NAD Levels A Randomized Double-Blind Parallel Trial
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this clinical trial is to determine if Qualia NAD effectively increases NAD levels in the blood and to evaluate its safety
Researchers will compare Qualia NAD to a placebo a look-alike substance that contains no active drug to assess its efficacy in increasing NAD levels in the blood
Participants will
Take Qualia NAD or a placebo every day for 4 weeks Undergo blood tests before and after the trial
Researchers will compare Qualia NAD to a placebo a look-alike substance that contains no active drug to assess its efficacy in increasing NAD levels in the blood
Participants will
Take Qualia NAD or a placebo every day for 4 weeks Undergo blood tests before and after the trial
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None